Kawasaki disease causes inflammation in the walls of medium-sized arteries throughout the body. It primarily affects children. The inflammation tends to affect the coronary arteries, which supply blood to the heart muscle.
Kawasaki disease is sometimes called mucocutaneous lymph node syndrome because it also affects lymph nodes, skin, and the mucous membranes inside the mouth, nose and throat.
Signs of Kawasaki disease, such as a high fever and peeling skin, can be frightening. The good news is that Kawasaki disease is usually treatable, and most children recover from Kawasaki disease without serious problems.
Kawasaki disease care at Mayo Clinic
Oct. 27, 2016
- Ferri FF. Kawasaki disease. In: Ferri's Clinical Advisor 2017. Philadelphia, Pa.: Elsevier; 2017. https://www.clinicalkey.com. Accessed Aug. 10, 2016.
- Kawasaki disease. National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/health/health-topics/topics/kd. Accessed Aug. 14, 2016.
- Kliegman RM, et al. Kawasaki disease. In: Nelson Textbook of Pediatrics. 20th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Aug. 10, 2016.
- Patel RM, et al. Kawasaki disease: A comprehensive review of treatment options. Journal of Clinical Pharmacy and Therapeutics. 2015;40:620.
- Lin KH, et al. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: A systematic review and meta-analysis. BMJ Open. 2015;5:1.
- Sundel R. Kawasaki disease: Initial treatment and prognosis. http://www.uptodate.com/home. Accessed Aug. 11, 2016.
- Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. June 6, 2016.